Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $624.66 billion, total revenue of $161.32 billion and a weighted average PE ratio of 50.62.
Market Cap
624.66B
Revenue
161.32B
Profits
12.34B
PE Ratio
50.62
Profit Margin
7.65%
Dividend Yield
0.24%
51 Stocks
No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
---|---|---|---|---|---|---|
1 | TMO | Thermo Fisher Scientific Inc. | 158.50B | -1.48% | 2,736,098 | 42.90B |
2 | DHR | Danaher Corporation | 143.82B | 0.14% | 2,051,702 | 23.82B |
3 | IDXX | IDEXX Laboratories, Inc. | 43.48B | 0.33% | 433,904 | 3.93B |
4 | A | Agilent Technologies, Inc. | 34.46B | 0.24% | 1,806,627 | 6.63B |
5 | IQV | IQVIA Holdings Inc. | 28.03B | -1.49% | 1,289,714 | 15.50B |
6 | MTD | Mettler-Toledo International Inc. | 25.33B | 1.00% | 175,792 | 3.83B |
7 | NTRA | Natera, Inc. | 22.09B | 2.06% | 1,175,144 | 1.83B |
8 | LH | Labcorp Holdings Inc. | 21.68B | 0.63% | 527,519 | 13.18B |
9 | WAT | Waters Corporation | 20.78B | 0.41% | 324,480 | 2.98B |
10 | DGX | Quest Diagnostics Incorporated | 19.38B | 0.65% | 871,070 | 10.16B |
11 | ILMN | Illumina, Inc. | 15.42B | -1.84% | 3,002,626 | 4.34B |
12 | ICLR | ICON Public Limited Company | 11.96B | -0.69% | 865,629 | 8.19B |
13 | RVTY | Revvity, Inc. | 11.80B | -0.53% | 911,354 | 2.77B |
14 | EXAS | Exact Sciences Corporation | 10.43B | 3.31% | 2,585,893 | 2.83B |
15 | QGEN | Qiagen N.V. | 10.39B | 0.23% | 1,750,884 | 2.00B |
16 | MEDP | Medpace Holdings, Inc. | 9.22B | -0.48% | 412,822 | 2.16B |
17 | CRL | Charles River Laboratories International, Inc. | 7.81B | 0.37% | 653,960 | 4.02B |
18 | GH | Guardant Health, Inc. | 6.32B | 0.43% | 1,713,765 | 774.00M |
19 | RDNT | RadNet, Inc. | 4.32B | 4.16% | 717,032 | 1.87B |
20 | SHC | Sotera Health Company | 3.30B | 0.17% | 757,843 | 1.11B |
21 | WGS | GeneDx Holdings Corp. | 2.62B | 7.82% | 1,080,970 | 330.14M |
22 | TWST | Twist Bioscience Corporation | 2.34B | 5.79% | 1,078,408 | 347.68M |
23 | VCYT | Veracyte, Inc. | 2.12B | 1.88% | 823,071 | 463.39M |
24 | GRAL | GRAIL, Inc. | 1.52B | -1.66% | 909,743 | 130.71M |
25 | NEOG | Neogen Corporation | 1.19B | 4.96% | 6,150,713 | 906.00M |
26 | CDNA | CareDx, Inc | 1.13B | 5.30% | 1,211,975 | 346.42M |
27 | OPK | OPKO Health, Inc. | 1.09B | 1.47% | 3,285,093 | 689.41M |
28 | NEO | NeoGenomics, Inc. | 969.07M | 1.07% | 1,955,069 | 672.36M |
29 | PSNL | Personalis, Inc. | 632.41M | 4.37% | 2,016,831 | 85.69M |
30 | FLGT | Fulgent Genetics, Inc. | 596.09M | 0.31% | 153,208 | 292.45M |
31 | CSTL | Castle Biosciences, Inc. | 580.91M | 1.82% | 412,675 | 347.08M |
32 | MYGN | Myriad Genetics, Inc. | 527.25M | 3.06% | 963,700 | 831.30M |
33 | XGN | Exagen Inc. | 149.31M | -1.73% | 153,104 | 56.72M |
34 | MDXH | MDxHealth SA | 108.89M | 0.92% | 34,143 | 94.51M |
35 | PRE | Prenetics Global Limited | 105.31M | -0.37% | 25,242 | 41.52M |
36 | FONR | FONAR Corporation | 97.34M | -0.83% | 13,914 | 103.02M |
37 | IMDX | Insight Molecular Diagnostics Inc. | 84.94M | 2.06% | 29,938 | 3.84M |
38 | NOTV | Inotiv, Inc. | 73.17M | 0.47% | 261,605 | 480.40M |
39 | BDSX | Biodesix, Inc. | 46.33M | 7.52% | 1,240,051 | 74.46M |
40 | BNR | Burning Rock Biotech Limited | 41.59M | 4.40% | 19,069 | 72.11M |
41 | PRPO | Precipio, Inc. | 24.56M | 2.40% | 26,085 | 20.03M |
42 | PRPH | ProPhase Labs, Inc. | 17.62M | -2.28% | 455,083 | 5.85M |
43 | ADVB | Advanced Biomed Inc. | 14.53M | 1.40% | 51,705 | - |
44 | BIAF | bioAffinity Technologies, Inc. | 9.36M | 1.49% | 3,618,725 | 8.81M |
45 | NDRA | ENDRA Life Sciences Inc. | 6.53M | 6.51% | 1,933,942 | - |
46 | MYNZ | Mainz Biomed N.V. | 6.36M | 27.59% | 418,929 | 893.99K |
47 | STRR | Star Equity Holdings, Inc. | 6.29M | - | 9,449 | 57.17M |
48 | XWEL | XWELL, Inc. | 5.23M | 9.10% | 64,734 | 32.19M |
49 | CHEK | Check-Cap Ltd. | 4.69M | -0.94% | 6,419 | - |
50 | APDN | Applied DNA Sciences, Inc. | 2.66M | -3.40% | 186,861 | 3.79M |
51 | ISPC | iSpecimen Inc. | 2.60M | - | 141,031 | 8.06M |